Protalix BioTherapeutics, Inc. (DE)Protalix BioTherapeutics, Inc. (DE)Protalix BioTherapeutics, Inc. (DE)

Protalix BioTherapeutics, Inc. (DE)

No trades
See on Supercharts

Price target

14.500.000.00%
The 2 analysts offering 1 year price forecasts for PLX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to PLX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PLX EPS for the last quarter is 0.03 USD despite the estimation of 0.06 USD. In the next quarter EPS is expected to reach 0.07 USD. Track more of Protalix BioTherapeutics, Inc. (DE) financials and stay on top of what is up with the company.
In the next quarter Protalix BioTherapeutics, Inc. (DE) revenue is expected to reach ‪18.75 M‬ USD. Check out Protalix BioTherapeutics, Inc. (DE) revenue and earnings and make informed decisions.
According to analysts, PLX price target is 14.50 USD with a max estimate of 15.00 USD and a min estimate of 14.00 USD. Check if this forecast comes true in a year, meanwhile watch Protalix BioTherapeutics, Inc. (DE) stock price chart and keep track of the current situation with PLX news and stock market news.